ORIC Stock Analysis: Buy, Sell, or Hold?

ORIC - Oric Pharmaceuticals, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$10.26
-0.50 (-4.65%) ▼
WAIT
LOW Confidence
Protect Your ORIC Gains
Last Updated: January 30, 2026
Earnings: Feb 17, 2026 16d

Get Alerted When ORIC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ORIC is down 14.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

In-depth Analysis How we analyze

Valuation Analysis: ORIC is currently trading at $10.26, which is considered slightly high relative to its 30-day fair value range of $8.22 to $11.54.

Technical Outlook: Technically, ORIC is in a downtrend. The price is currently testing key support at $10.22. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.6% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.00 (+95.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $8.22 - $11.54
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 61.6%

Protect Your Profits

Holding ORIC? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.6%)
  • BULLISH: Trading 95.2% below Wall St target ($21.00)
  • WARNING: Recommendation downgraded due to -14.4% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $8.22 - $11.54
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $10.22
Resistance Level $12.70
Current Trend Downtrend

Fundamental Context

Forward P/E (Next Year Est.) -6.77
Wall Street Target $21.00 (+95.2%)
Last updated: January 30, 2026 10:01 PM ET
Data refreshes hourly during market hours. Next update: 11:01 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Jacob Chacko SELL 37461 shares 2025-10-06
Dominic Piscitelli SELL 11000 shares 2025-10-06
Jacob Chacko SELL 53001 shares 2025-10-01

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$21 54 HOLD
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
33 analysts
$486 45 HOLD
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$500 62 BUY
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$91 64 BUY
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$830 52 HOLD

Advanced ORIC Option Strategies

Professional options setups generated by AI based on today's ORIC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ORIC

ORIC Technical Chart ORIC Price Prediction ORIC Earnings Date ORIC Investment Advisor ORIC Fair Price Analyzer ORIC Options Advisor ORIC Options Chain ORIC Options Analysis ORIC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals